4 January 2024
Iconic Labs PLC
("Iconic" or the "Company")
Board Changes
Business and Strategy Update
Iconic Labs PLC (LSE: ICON), is pleased to announce the appointment of Victor Humberdot and Bela Lendvai-Lintner as Non-executive Directors to the Board of Iconic, as well as an update on the business and strategy of the Company.
Board Changes
Victor Humberdot and Bela Lendvai-Lintner have been appointed as Non-executive Directors with immediate effect and will replace Marija Hrebac, David Stybr and Emmanuel Blouin who have stepped down from the Board.
Victor Humberdot (aged 34) is an experienced investment banker. Having started his career at BBVA and Kepler Cheuvreux, he then joined the investment fund of Société Générale, Private Banking in Luxembourg before, most recently, being responsible for the external growth of an investment holding company in the construction sector before being M&A Manager at Exponens Corporate Finance and more recently a Vice President at the corporate finance boutique, DDA & Company in
Bela Lendvai-Lintner (aged 48) has more than 20 years of experience in private equity within a wide range of industry sectors. He started his career at KPMG in corporate finance focused on M&A transactions. Bela has also held multiple roles at ARX Equity Partners, an independent
Business and Strategy Update
In conjunction with these Board changes, Iconic is also focusing on its strategy. Earlier in 2023, Iconic intended to establish a strategic advisory services business, engaging in fee-based service contracts with technology companies. The objective was to provide valuable guidance on growth plans, product development, marketing and capital raising.
However, following the successful Company restructuring, and its exit from administration, Iconic is now channelling all its efforts towards identifying a suitable acquisition target, most likely in the form of a reverse takeover ("RTO") target. Whilst the Company continues to narrow down the pool of viable acquisition candidates, in parallel, Iconic will continue to develop, with its strategic partners, its sole asset, Gay Star News, an online media platform dedicated to the LGBTQ+ community.
Iconic is confident that this strategic shift will pave the way for long-term growth and create substantial value for its shareholders.
Brad Taylor, Chief Executive Officer of Iconic Labs PLC, commented:
"I would like to extend my gratitude to Marija, Emmanuel and David for their unwavering support and guidance in navigating us through the complex restructuring of the Company with an exceptionally high level of professionalism and skill.
"As the Company pivots to focus all efforts on acquiring a suitable company through an RTO, I welcome Victor and Bela to the Board and look forward to working closely with them, who between them bring a blend of finance and industry experience to the Board which will prove invaluable in achieving our strategic objective of fostering long-term growth and value for all our shareholders."
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of
Additional Information
Bela Lendvai-Lintner is currently or has been Director or Partner of the following companies and/or firms in the last five years:
Current Directorships
Accounting Partners Hungary Kft
XMobile International Kft
Pannon Provider Zrt
Beer=Win Holding Kft
Orenthal Kft
Previous Directorships
Gomba Invest Kft
Victor Humberdot is currently or has been Director or Partner of the following companies or firms in the last five years:
Current Directorships
HUVI Capital
IPAHUMA
Previous Directorships
Quickcool AB
For any further information or enquiries please contact:
Iconic Labs Brad Taylor, Chief Executive Officer |
Tel: +44 (0) 7462 156238 ir@iconiclabs.co.uk |
Novum Securities Limited David Coffman / Daniel Harris |
Tel: +44 (0) 20 7399 9400
|
Yellow Jersey PR Sarah Hollins Annabelle Wills Bessie Elliot
|
Tel: +44 (0) 20 3004 9512 iconic@yellowjerseypr.com
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.